← Research ProtocolsKisspeptin-10
STUDIED EXPOSURE MAP / 2011
Kisspeptin-10
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
HUMAN / DOSE RESPONSEJ CLIN ENDOCRINOL METABSTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
0.3 nmol/kg
IV bolus
1.0 nmol/kg
IV bolus
3.0 nmol/kg
IV bolus
10 nmol/kg
IV bolus
Context: These are acute experimental bolus exposures. They are not a chronic protocol and are reported in molar units because that is how the study was designed.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / J CLIN ENDOCRINOL METAB
The Effects of Kisspeptin-10 on Recompoundive Hormone Release Show Sexual Dimorphism in Humans
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
2011
01 / DESIGNControlled human dose-response experiments
02 / POPULATION / MODELHealthy male and female volunteers
03 / ROUTEIntravenous bolus; additional route experiments were also performed
04 / TIMEFRAMEAcute endocrine-response sampling
05 / PRIMARY QUESTIONLH and FSH responses
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
KISS1R and recompoundive-axis research
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.